Humana Inc. stock price, HUM

Humana Inc. stock chart:



Humana Inc. close price: 231.99

Stock price forecast:

DOWN TO -0.14%
Target: 231.67

Total forecasts: 85
Reached: 0 (0.00%)

Total Win: 0.00 (0.00%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
908500.00%0.000.00%19,149.24-569.91-2.98%-569.91-2.98%
303100.00%0.000.00%7,191.690.000.00%0.000.00%
141500.00%0.000.00%3,479.850.000.00%0.000.00%
7800.00%0.000.00%1,855.920.000.00%0.000.00%

Showing 1-10 of 592 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-06-26231.99231.670000-00-00
2017-06-25231.99231.660000-00-00
2017-06-24231.99231.660000-00-00
2017-06-23231.99231.660000-00-00
2017-06-22231.99231.650000-00-00
2017-06-21231.99231.390000-00-00
2017-06-20231.99231.240000-00-00
2017-06-19231.992310000-00-00
2017-06-18231.99230.890000-00-00
2017-06-17231.99230.670000-00-00

Humana Inc. latest news:


  • 06/22/2017 11:26:50

    GOP health bill boosts hospital, health insurer and drug stocks

    Hospital system stocks rallied as much as 8% on Thursday following the release of the Senate GOP health bill, which appears to be more favorable to hospitals than the House of Representatives bill passed in early May. Tenet Healthcare Corporation shares jumped 8%, Community Health Systems Inc. shares skyrocketed 8.2%, HCA Healthcare Inc. shares rose 3.6% and Universal Health Services Inc. shares lifted 2.6% in midday trade, compared with a 1.6% rise in the Health Care Select Sector SPDR . Health insurer stocks also rose Tuesday, with UnitedHealth Group shares up 1.4%, Aetna Inc. stock rising 1.1%, Humana Inc. shares lifting 1.3% and Anthem Inc. shares up 0.9%, compared with a 0.2% rise in the S&P 500 . The Senate health bill "tries to phase in the pain" of changes to the Affordable Care Act like Medicaid spending cuts, said Spencer Perlman, director of health-care research at Veda Partners, who described the Senate plan as having "the same architecture" but "nicer furnishings." Still, the benefit for hospitals is only in the short-term and thus probably overdone, he said. "Clearly, the Senate bill is viewed as less disruptive than the House bill to the number of people currently receiving insurance," said Stephanie Miller, senior analyst at Height Securities. But "the initial reaction may have oversimplified how different this bill is," she said, predicting that stocks that have risen on the news may be "rebalancing" in the coming days. Drug stocks also rose in Tuesday trade, with the SPDR S&P Pharmaceutical ETF rising 1.7% and the SPDR S&P Biotech ETF rising 1.6%, which could be happening because the health bill has given investors confidence in Republicans achieving another legislative priority, tax reform, Miller said. Shares of the Health Care Select Sector SPDR have risen 8.7% over the last three months, compared with a 3.9% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 06/05/2017 14:38:13

    BRIEF-Humana expects to reaffirm guidance of at least $11.10 in adj EPS for year ending Dec 31 2017

    Humana Inc(HUM): * Humana - expects to reaffirm guidance of at least $16.91 in diluted eps, or at least $11.10 in adjusted eps, in each case for year ending dec 31, 2017. * Fy2017 earnings per share view $11.15 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

  • 05/03/2017 11:11:46

    BRIEF-Humana says individual medicare advantage membership up 1.2 pct from March 31, 2016 to March 31, 2017

    * Individual medicare advantage membership increased 32,500 members, or 1.2%, from March 31, 2016 to March 31, 2017 - SEC filing

  • 05/02/2017 09:38:09

    Insurer Aetna posts loss, evaluates Obamacare exposure

    - Aetna Inc (AET) reported a quarterly net loss on Tuesday related to costs from its failed acquisition of Humana Inc and said it will cut exposure to money-losing Obamacare coverage in 2018.

  • 05/02/2017 04:49:47

    Aetna books 1Q loss on failed Humana bid, ups 2017 forecast

    Aetna booked a $381-million loss, mainly due to its failed bid for rival Humana, but ups its outlook for the year

  • More trends:

    Huntington Ingalls IndustriesHII | Huntsman CorporationHUN | Hyatt Hotels CorporationH | Hyster-Yale Materials HandlingHY | Iamgold CorporationIAG | ICICI Bank LimitedIBN | IDACORPIDA | IDEX CorporationIEX | IDT CorporationIDT | IHS Inc.IHS |